Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2020 June;45(2) > Minerva Endocrinologica 2020 June;45(2):117-26

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

ORIGINAL ARTICLE   

Minerva Endocrinologica 2020 June;45(2):117-26

DOI: 10.23736/S0391-1977.19.03007-4

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

Selected adipocytokines in patients with an incidentally discovered pheochromocytoma

Anna BABINSKA 1 , Mariusz KASZUBOWSKI 2, Piotr KMIEĆ 1, Krzysztof SWORCZAK 1

1 Department of Endocrinology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland; 2 Institute of Statistics, Department of Economic Sciences, Faculty of Management and Economics, Gdansk University of Technology, Gdansk, Poland



BACKGROUND: Adipose tissue secretes many adipokines and cytokines, which may be an additional risk factor of cardiovascular and metabolic diseases in patients with an incidentally discovered pheochromocytoma (PHEO). The aim of the study was to investigate levels of selected adipocytokines in these patients.
METHODS: This prospective study included 12 patients with an incidentally discovered PHEO and 18 healthy participants. In all participants plasma/serum concentrations of triglycerides, HDL and LDL cholesterol, insulin, glucose, adipocytokines (adiponectin, leptin, resistin, TNFα, IL6, and MCP1) were determined, hormonal tests were performed in patients.
RESULTS: Patients and controls did not differ significantly in terms of age, sex, and body mass index. Among incidentally discovered PHEO patients, adiponectin levels were lower, while TNFα concentrations higher than in controls. Concentrations of adiponectin correlated with 24-hour urinary excretion of normetanephrine in women. Significantly higher TNFα concentrations were found in hypertensive than in normotensive PHEO patients as well as in non-diabetic PHEO patients than controls. Further, resistin concentration was higher in PHEO patients with diabetes than in non-diabetic ones (P<0.001). Incidentally discovered PHEO tumor size correlated with leptin and IL6 levels. Adiponectin levels were higher, while TNFα and resistin lower among five patients re-examined after tumor resection.
CONCLUSIONS: Among patients with an incidentally discovered pheochromocytoma, lower adiponectin, and higher resistin and TNFα levels may constitute additional factors for HT and DM. In our study, for the first time, correlations between incidentally discovered PHEO tumor size and concentrations of leptin as well as IL6 were found.


KEY WORDS: Adipokines; Cytokines; Pheochromocytoma; Diabetes mellitus; Hypertension

top of page